Outcome of Primary Mediastinal Large B Cell Lymphoma Treated with RCHOP

PURPOSE: Primary mediastinal large B-cell Lymphoma (PMLBCL) is a rare aggressive lymphoma with unique clinical, pathological, and molecular features. The optimal frontline therapy is subject of ongoing debate. Our study aims to evaluate the outcomes of PMLBCL treated with rituximab, cyclophosphamide...

Descripción completa

Detalles Bibliográficos
Autores principales: Halahleh, Khalid, Yaseen, Abeer, Muradi, Isra, Al-Ibraheem, Akram, Sultan, Iyad, Ma’koseh, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9952517/
https://www.ncbi.nlm.nih.gov/pubmed/36846350
http://dx.doi.org/10.2147/JBM.S393180

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9952517/
https://www.ncbi.nlm.nih.gov/pubmed/36846350
http://dx.doi.org/10.2147/JBM.S393180

Ejemplares similares